MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-23-2026
Accelerate Diagnostics ROA Ratio 2011-2026 | AXDX
Annual ROA Ratio Accelerate Diagnostics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -175.25 | -196.45 | -96.12 | -27.46 | -83.71 | -62.72 | -47.68 | -51.01 | -80.11 | -32.66 | -44.32 | -35.19 | -30.85 | -6.05 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.05 | -196.45 | -69.25 |
Quarterly ROA Ratio Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -139.98 | -160.31 | -142.56 | -96.25 | -117.2 | -151.06 | -104.57 | -71.64 | -99.1 | -89.21 | -80.73 | -87.75 | -80.53 | -87.46 | -81.15 | -72.75 | -68.38 | -64.25 | -60.62 | -55.48 | -51.59 | -48.73 | -46.25 | -43.4 | -44.4 | -45.94 | -46.39 | -55.71 | -62.21 | -67.56 | -72.63 | -65.54 | -55.51 | -62.6 | -69.41 | -71.46 | -74.56 | -61.3 | -48.3 | -46.81 | -46.13 | -42.67 | -45.58 | -41.18 | -31.73 | -30.3 | -22.8 | -21.52 | -19.53 | -19.57 | -13.54 | -13.53 | -6.88 | 0.65 | -6.87 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.65 | -160.31 | -62.04 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
-4.99 | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
-37.95 | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
1.41 | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
12.79 | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
23.41 | - | - | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | - | - | $ 6.94 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
Natera
NTRA
|
-8.68 | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 25.99 | 2.52 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-83.65 | - | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | - | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 376.47 | -0.87 % | $ 22.4 B | USA |